• Veeva Systems remains on track for its $6 billion 2030 target, according to its November 5, 2026, investor presentation.
• Its estimated life sciences addressable market exceeds $30 billion, with the biopharma and medical technology industry growing more than 6%.
• The quality business has a revenue run rate exceeding $600 million, serving more than 600 customers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veeva Systems Inc. published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.